Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efalizumab Conversion in Renal Transplant
NCT00472082Phase 2Terminated
- Sponsor
- Emory University
- Start
- May 2007
- Primary completion
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of efalizumab in kidney transplant rejection, sponsored by Emory University. Started May 2007; status: terminated.
02
Drugs
efalizumab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00472082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00472082.